Results 121 to 130 of about 4,505,998 (338)
Molecular Oncology, EarlyView.The COMBAT classification system, developed through multi‐omics integration, stratifies adult patients with B‐cell acute lymphoblastic leukemia(B‐ALL) into three molecular subtypes with distinct surface antigen patterns, immune landscape, methylation patterns, biological pathways and prognosis.
Yang Song +11 more
wiley +1 more source
Optimal Control Prediction Method for Control Allocation [PDF]
This paper proposes a novel prediction method for online optimal control allocation that extends the volume of moments achievable with the Moore-Penrose generalized inverse to the entire Attainable Moment Set.
Acheson, Michael J.
core +1 more source
Closure to “Discussions of ‘A Uniform Approach to the Optimum Adjustment of Control Loops’” (1954, Trans. ASME, 76, pp. 1273–1278) [PDF]
, 1954 Rudolf Oldenbourg, Hans Sartorius
openalex +1 more source
Molecular Oncology, EarlyView.In patients treated with atezolizumab as a part of the MyPathway (NCT02091141) trial, pre‐treatment ctDNA tumor fraction at high levels was associated with poor outcomes (radiographic response, progression‐free survival, and overall survival) but better sensitivity for blood tumor mutational burden (bTMB).
Charles Swanton +17 more
wiley +1 more source
Discussion: “Optimum Nonlinear Control” (Oldenburger, Rufus, 1957, Trans. ASME, 79, pp. 527–542) [PDF]
, 1957 T. M. Stout
openalex +1 more source
Molecular Oncology, EarlyView.Non‐thermal plasma treatment of melanoma cells induced epithelial‐mesenchymal transition (EMT) in a dose‐dependent fashion. This report highlights the critical need to further investigate potential adverse effects of non‐thermal plasma for cancer therapy and to optimize treatment parameters for clinical translation. Despite the promising results of non‐
Eline Biscop +10 more
wiley +1 more source
Closure to “Discussions of ‘Optimum Nonlinear Control’” (1957, Trans. ASME, 79, pp. 542–545) [PDF]
, 1957 Rufus Oldenburger
openalex +1 more source
Molecular Oncology, EarlyView.Trastuzumab‐deruxtecan, a HER2‐targeting antibody‐drug conjugate, shows promising antitumor activity in head and neck squamous cell carcinoma with low HER2 expression. In vitro and in vivo studies demonstrated dose‐dependent cell death and tumor growth reduction in low HER2‐expressing cell lines, which correlated with drug accumulation measured using a
Abdullah Bin Naveed +8 more
wiley +1 more source
Simultaneous Control of Cost Dynamics and Transport in Network Systems
IEEE AccessTransportation networks, including infrastructures such as roads and power transmission, are crucial for supporting modern society. However, these networks are frequently exposed to risks such as natural disasters, e.g., earthquakes and hurricanes.
Koshi Oishi +5 more
doaj +1 more source
Unraveling LINE‐1 retrotransposition in head and neck squamous cell carcinoma
Molecular Oncology, EarlyView.The novel RetroTest method allows the detection of L1 activation in clinical samples with low DNA input, providing global L1 activity and the identification of the L1 source element. We applied RetroTest to a real‐world cohort of HNSCC patients where we reported an early L1 activation, with more than 60% of T1 patients showing L1 activity.
Jenifer Brea‐Iglesias +12 more
wiley +1 more source